Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intra-Cellular Ther (ITCI)

Intra-Cellular Ther (ITCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Intra-Cellular Ther 430 EAST 29TH STREET NEW YORK NY 10016 USA

P: 646-440-9333 F: 646-440-9334

Description:

Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 563,662
Shares Outstanding, K 55,261
Annual Sales, $ 0 K
Annual Net Income, $ -155,130 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -34,860 K
60-Month Beta 1.21
% of Insider Shareholders 18.20%
% of Institutional Shareholders 71.82%
Float, K 45,204
% Float 81.80%

Growth:

1-Year Return -24.61%
3-Year Return -34.19%
5-Year Return -35.40%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -82.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/05/19
Earnings Per Share ttm -2.69
EPS Growth vs. Prev Qtr 7.35%
EPS Growth vs. Prev Year 17.11%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ITCI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -6.59
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -54.27
Return-on-Assets (Before Tax) -45.84
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.08
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.43
Book Value/Share 4.11
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar